Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Will a unique form of ginseng be clinically helpful in those with chronic fatigue syndrome and fibromyalgia?
Ginseng has been shown in earlier studies to help fatigue in a number of conditions. But because of overharvesting, most ginseng is no longer have optimal levels of the active ginsenosides. A new technique has been developed to restore the level of active ginseng components those found in the wild ginseng used in earlier studies. This is available in a form called HRG 80 Red Ginseng.
The study is an open pilot study to explore whether this treatment would be helpful for improving clinical function and symptomatology in chronic fatigue syndrome and fibromyalgia. Current clinical experience is suggesting that it may be.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Active Ginseng treatment | Experimental | People with CFS or Fibromyalgia will receive HRG 80 Red GInseng |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| HRG 80 Red Ginseng | Dietary Supplement | A unique form of ginseng with the high level of active ginseng components similar to those found in the wild ginseng used in earlier studies. |
| Measure | Description | Time Frame |
|---|---|---|
| Composite Visual analog scale of symptoms | Composite Score visual analog scale (0 - 30 Visual analog scale units , with 30 VAS units representing optimal function) of energy, cognition, and overall well-being. Each on a 0-10 scale with 10 being healthy. The units are the same for all 3 allowing them to be combined into a single composite total score. This total score (0-30 with 30 being the best outcome ) is the primary outcome measure | 6 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| VAS of pain and sleep | VAS of pain and sleep | 6 weeks |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Jacob Teitelbaum, MD | Contact | 4105627409 | FatigueDoc@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Jacob Teitelbaum | FFTF LLC | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Kona Research Center | Recruiting | Kailua | Hawaii | 96740 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D005356 | Fibromyalgia |
| ID | Term |
|---|---|
| D009135 | Muscular Diseases |
| D009140 | Musculoskeletal Diseases |
| D012216 | Rheumatic Diseases |
| D009468 | Neuromuscular Diseases |
Not provided
Not provided
Open label study
Not provided
Not provided
Not provided
Not provided
| D009422 |
| Nervous System Diseases |